Leif-Ann Tuohey

Leif-Ann Tuohey is the SVP & Head of Business Development at Rectify Pharma. Leif-Ann has over 15 years of experience in the pharmaceutical industry, with a focus on business development, licensing, and alliance management.

Leif-Ann started their career as a Senior Analyst at Health Advances, a healthcare consulting firm. Leif-Ann then spent a summer as an MBA intern at Schering-Plough Pharmaceuticals before joining Purdue Pharma as a Senior Manager of Licensing & Business Development.

In 2011, Leif-Ann joined Infinity Pharmaceuticals as an Associate Director of Corporate and Business Development. At Infinity, they were responsible for leading in-licensing and out-licensing activities as well as developing corporate strategy. In 2017, they joined X4 Pharmaceuticals as Vice President, Head of Business Development. At X4, they were employee number 19 and was responsible for business development, alliance management, intellectual property, contracts, and corporate communications.

Leif-Ann has a bachelor's degree in Biology from Tufts University and an MBA from the Tuck School of Business at Dartmouth College.

Leif-Ann Tuohey has a MBA from Harvard Business School and a B.A. in Biochemical Sciences from Harvard University.

Some of their coworkers include Jonathan Moore - Founder & Chief Scientific Officer, Tracey Dawson - COO, and Janeta Popovici-Muller - SVP & Head, Drug Discovery. Leif-Ann Tuohey reports to Rajesh Devraj, President & CEO.